Evidence map›Paper›PMID 36522188›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2023

Imaging Diverse Pathogenic Bacteria In Vivo with

Spenser R Simpson, Alexandria E Kesterson, Justin H Wilde, Zoraiz Qureshi, Bijoy Kundu, Mark P Simons, Kiel D Neumann

Open access · hybridAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Discovery of a Thermostable Nigerose Phosphorylase for the Efficient Chemoenzymatic Radiosynthesis of aJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Automated radiosynthesis of [Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine · 2025
    Article
  9. Automated radiosynthesis of [EJNMMI radiopharmacy and chemistry · 2025
    Article
  10. ACS infectious diseases · 2025
    Article
  11. Pilot Evaluation of S-(3-[Molecular imaging and biology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Chemoenzymatic Syntheses of Fluorine-18-Labeled Disaccharides from [Journal of the American Chemical Society · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Spenser R SimpsonDepartment of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee.
Alexandria E KestersonCombat Wounds Division, Naval Medical Research Center, U.S. Navy, Silver Spring, Maryland.
Justin H WildeDepartment of Radiology and Medical Imaging, University of Virginia, Charlottesville, Virginia.
Zoraiz QureshiDepartment of Radiology and Medical Imaging, University of Virginia, Charlottesville, Virginia.
Bijoy KunduDepartment of Radiology and Medical Imaging, University of Virginia, Charlottesville, Virginia.
Mark P SimonsCombat Wounds Division, Naval Medical Research Center, U.S. Navy, Silver Spring, Maryland.
Kiel D NeumannDepartment of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee; kiel.neumann@stjude.org.
University of Virginia · USNaval Medical Research Command · USSt. Jude Children's Research Hospital · US

Funding

Novel imaging agents of oxidative stress in the pathophysiology of the central nervous systemR01EB028338 · NIBIB · UNIVERSITY OF VIRGINIA · PI NEUMANN, KIEL · 2020 to 2020
$2.1M
NIBIB NIH HHS R01 EB028338
6 · The paper itself

Abstract

Infectious disease remains the main cause of morbidity and mortality throughout the world. Of growing concern is the rising incidence of multidrug-resistant bacteria, derived from various selection pressures. Many of these bacterial infections are hospital-acquired and have prompted the Centers for Disease Control and Prevention in 2019 to reclassify several pathogens as urgent threats, its most perilous assignment. Consequently, there is an urgent need to improve the clinical management of bacterial infection via new methods to specifically identify bacteria and monitor antibiotic efficacy in vivo. In this work, we developed a novel radiopharmaceutical, 2-

Indexed as

Staphylococcal InfectionsStaphylococcus aureusAnimalsAnti-Bacterial AgentsBacteriaGram-Negative BacteriaGram-Positive BacteriaMammalsMicePositron-Emission TomographyPositron Emission Tomography Computed TomographyRadiopharmaceuticalsAnti-Bacterial AgentsRadiopharmaceuticals18FbacteriainfectionPET imaging

Identifiers

PMID36522188
PMCPMC10152124
OpenAlexW4311668379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.